β-Blockers After Myocardial Infarction in Patients With Preserved Ejection Fraction
This meta-analysis of four randomized trials confirmed that beta-blockers after MI in patients with preserved ejection fraction do not improve cardiovascular outcomes. The consolidated evidence definitively supports discontinuation in this population.
Summary
This meta-analysis of 4 randomized clinical trials assesses whether β-blockers are associated with improved cardiovascular outcomes after myocardial infarction in patients with preserved left ventricular ejection fraction.
Join us
Join the Global Primary Care Cardio Network. Membership is free.
Would you like to tell us more about yourself?
Interests
We will send you an email with a link to confirm your registration.
